Essential Partners LLC
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 2136442
RANCHO SANTA FE, CA
Position in NAMS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,796
+$1,732 QoQ
Shares Held
53
+2550.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#189
of 198 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Essential Partners LLC holds $3,266,429 across 185 Biotechnology names. NAMS ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
6,122 | $693,989 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
713 | $444,584 | |
| 3 | EXEL |
Exelixis, Inc.
|
6,620 | $360,194 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378 | $187,763 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
3,131 | $179,155 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
1,384 | $120,338 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
328 | $79,038 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
252 | $75,859 |
All Filings in NAMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,796 | 53 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $64 | 2 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $70 | 2 | Shares | Sole | 2026-05-21 | |
| 2025-09-30 | $56 | 2 | Shares | Sole | 2026-05-21 | |
| 2025-06-30 | $36 | 2 | Shares | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||